Clinical Trial Update: Immunotherapy and Paraneoplastic Neurological Syndromes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating an immunotherapy for Paraneoplastic Neurological Syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Paraneoplastic Neurological Syndromes

Drugs mentioned

• Immunotherapy (unspecified)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Paraneoplastic Neurological Syndromes | Phase 2 | Status: COMPLETED